Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07572071
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's DiseaseIran University of Medical SciencesRecruitingPhase 1
NCT07572071Recruiting
Phase 1
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Park...Iran University of Medica...
NCT07573150
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing TonsillectomyNational Institute on Drug Abuse (NIDA)Not Yet Recruiting
NCT07573150Not Yet Recruiting
—
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Dep...National Institute on Dru...
NCT07574151
Accessing the Clarity and Acceptability of Recruitment Materials for a Study on Thoracic Aortic Disease SurveillanceUniversity of NottinghamRecruiting
NCT07574151Recruiting
—
Accessing the Clarity and Acceptability of Recruitment Materials for a Study on...University of Nottingham
NCT07572201
The Effect of Kinesio Taping Applied to the Gastrocnemius Muscle on Muscle Oxygenation, Pain Pressure Threshold, and Muscle Mechanical PropertiesOkan UniversityNot Yet RecruitingNot Applicable
NCT07572201Not Yet Recruiting
Not Applicable
The Effect of Kinesio Taping Applied to the Gastrocnemius Muscle on Muscle Oxyge...Okan University
NCT07574021
The Experience of Short Video Addiction Among College StudentsSun Yat-sen UniversityNot Yet Recruiting
NCT07574021Not Yet Recruiting
—
The Experience of Short Video Addiction Among College StudentsSun Yat-sen University
NCT07572175
Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityAmerican Heart AssociationNot Yet RecruitingPhase 2
NCT07572175Not Yet Recruiting
Phase 2
Sotagliflozin as Prevention of Anthracycline-Related CardiotoxicityAmerican Heart Associatio...
NCT07574281
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in EthiopiaAddis Ababa UniversityNot Yet RecruitingNot Applicable
NCT07574281Not Yet Recruiting
Not Applicable
Effectiveness and Implementation of the DINKNESH Digital Palliative Care Tool in...Addis Ababa University
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07574112
Muscle Energy Technique With And Without Myofascial Release in Patients With Cervicogenic HeadacheUniversity of LahoreCompletedNot Applicable
NCT07574112Completed
Not Applicable
Muscle Energy Technique With And Without Myofascial Release in Patients With Cer...University of Lahore
NCT07572357
Clinical Evaluation of the RH210 Hearing AidGlobal Edge Medtech ConsultingNot Yet RecruitingNot Applicable
NCT07572357Not Yet Recruiting
Not Applicable
Clinical Evaluation of the RH210 Hearing AidGlobal Edge Medtech Consu...
NCT07574359
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes in the Russian PopulationPirogov Russian National Research Medical UniversityRecruiting
NCT07574359Recruiting
—
RUSS-AGE: Creating of a Biological Age Calculator and Study of Aging Phenotypes...Pirogov Russian National...
NCT07573267
Effects of Myofascial Release, Dynamic and Static Stretching in Adolescent Karate AthletesIstinye UniversityCompletedNot Applicable
NCT07573267Completed
Not Applicable
Effects of Myofascial Release, Dynamic and Static Stretching in Adolescent Karat...Istinye University
NCT07574177
Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiovascular HealthUniversity of South AlabamaNot Yet RecruitingNot Applicable
NCT07574177Not Yet Recruiting
Not Applicable
Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiova...University of South Alaba...
NCT07573436
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)ADC Therapeutics S.A.Not Yet RecruitingPhase 1
NCT07573436Not Yet Recruiting
Phase 1
Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post...ADC Therapeutics S.A.
NCT07572123
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07572123Not Yet Recruiting
Phase 2
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treat...National Cancer Institute...
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07573241
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Complementary and Integrative Health (NCCIH)Not Yet RecruitingNot Applicable
NCT07573241Not Yet Recruiting
Not Applicable
Single Arm Trial Identifying Barriers and Facilitators to Mindfulness PracticeNational Center for Compl...
NCT07574047
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.Swiss Cancer InstituteNot Yet RecruitingPhase 4
NCT07574047Not Yet Recruiting
Phase 4
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for...Swiss Cancer Institute
Result Breakdown
Not yet recruiting13 (65%)
Recruiting5 (25%)
Completed2 (10%)
not_applicable9 (45%)
Not Specified5 (25%)
Phase 13 (15%)
Phase 22 (10%)
Phase 41 (5%)